Work

Phase II Trial of Recombinant Human Interleukin-4 in Patients with Disseminated Malignant Melanoma

Year: 1998

Type: article

Study design: Clinical Trial

Source: Journal of Immunotherapy

DOI: 10.1097/00002371-199811000-00006

Authors: Robert P. Whitehead, Joseph M. Unger, J. Wendall Goodwin, Michael J. Walker, John A. Thompson, Lawrence E. Flaherty, Vernon K. Sondak

Institutions: The University of Texas Medical Branch at Galveston, SWOG Cancer Research Network, The Ohio State University, Fred Hutch Cancer Center, Wayne State University, University of Michigan

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G2064543036, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3411601502, SOUTHWEST ONCOLOGY GROUP, Southwest Oncology Group Treatment Grant, G763325562

OpenAlex ID: W2027940608

FWCI: 1.027

Cites:

Cited by: 47

Related to: 10